Theravance Biopharma Vs. Nukkleus Industry Stock Comparison

Buy

51

TBPH
Theravance Biopharma

Last Price:

$9.62

Seasonality Move:

0.44%

Sell

46

NUKK
Nukkleus

Last Price:

$40.15

Seasonality Move:

-21.57%

Buy

51

Theravance Biopharma (TBPH) is a Buy

Is Theravance Biopharma a Buy, Sell or Hold?

The current Theravance Biopharma [TBPH] share price is $9.60. The Score for TBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
TBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

46

Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBPH Stock Price Chart

What is Theravance Biopharma's stock price today?

The Theravance Biopharma share price today is $9.60

The current trend is moderately bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

The Nukkleus share price today is $40.00

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

TBPH Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.16	Buy
Relative Strength Index (14 RSI):	50.37	Buy
Chaikin Money Flow:	-218313	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.47 - 9.95)	Sell
Bollinger Bands (100):	(7.98 - 9.44)	Buy

NUKK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	8.69	Buy
Relative Strength Index (14 RSI):	77.28	Buy
Chaikin Money Flow:	-1366926	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(-7.5 - 22.6)	Buy
Bollinger Bands (100):	(-4.22 - 11.5)	Buy

TBPH Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	9.83	Sell
20-day SMA:	9.71	Sell
50-day SMA:	9.18	Buy
200-day SMA:	8.9	Buy
8-day EMA:	9.77	Sell
20-day EMA:	9.68	Sell
50-day EMA:	9.31	Buy
200-day EMA:	9.06	Buy

NUKK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	20.07	Buy
20-day SMA:	9	Buy
50-day SMA:	4.99	Buy
200-day SMA:	4.78	Buy
8-day EMA:	26.51	Buy
20-day EMA:	14.21	Buy
50-day EMA:	7.47	Buy
200-day EMA:	11.77	Buy

Theravance Biopharma Earnings Growth & TBPH Earnings Dates

Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $1.08 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Theravance Biopharma Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):